Frontiers in Oncology Journal Citation Rate 2026
2234-943X
Frontiers Media
CH
Q2 Quartile Open Access Established Impact
About Frontiers in Oncology
Frontiers in Oncology (FO) is a peer-reviewed academic journal, published by Frontiers Media in CH, catalogued under ISSN 2234-943X. As of 2026, it has a 2025 2-Year Citation Rate (OpenAlex) of 2.27 (Q2 quartile) — the average number of citations its recent articles received over a two-year window, computed from OpenAlex open citation data, not the Clarivate (JCR) Impact Factor. It is fully open access.
Frontiers in Oncology Citation Rate 2026 — In Context
Frontiers in Oncology has a 2025 2-Year Citation Rate (OpenAlex) of 2.27, placing it in the Q2 quartile. This is the average number of citations the journal's recent articles received over a two-year window, computed from OpenAlex open citation data — not the Clarivate (JCR) Journal Impact Factor.
As a fully open-access publication, Frontiers in Oncology makes all articles freely available to readers.
Researchers looking to publish in Frontiers in Oncology should review the journal's submission tips and verify the latest indexing status against Scopus, DOAJ, and Web of Science using our indexing tracker. To compare Frontiers in Oncology against similar journals in the field, use our journal comparison tool.
| ISSN (Print) | 2234-943X |
|---|---|
| Publisher | Frontiers Media |
| Country | Switzerland |
| APC / Cost | Inquire with Publisher |
In-depth profile & metrics
Frontiers in Oncology is published by Frontiers Media and based in Switzerland. It publishes on an open-access basis.
Its most recent citation rate stands at 2.272.
Links
Continue on JournalsHub
Put what you just read into practice with these free tools.
Frequently Asked Questions about Frontiers in Oncology
Live Indexing Status
Updated July 2026Track real-time indexing metrics to ensure this journal meets your academic requirements.
Citation Rate
Historical Trend
Initial data points onlyCitation Rate by Year
| Year | Value | Source |
|---|---|---|
| 2025 | 2.272 | 2-Year Mean Citedness (OpenAlex) |
Metrics are sourced from OpenAlex, DOAJ and Scopus and reflect the latest data we hold. The headline figure is a 2-year citation rate (OpenAlex), not a Clarivate Impact Factor. Always verify against the journal's official site before relying on it. See our Methodology or report a correction.
Research Highlights
Recently published high-impact papers in this journal:
-
Symptom networks in breast cancer patients during chemotherapy and their impact on daily living status
Yuxuan Zhang, Huoling Pan, Jinyu Zhang • 2026
-
SinglePass Kronos electrocautery device for closure of liver mass image-guided biopsy: a series of five case reports
Tust Techasith, Abhishek Jairam, Thomas Velling • 2026
-
Progress in molecular markers associated with radiotherapy efficacy in glioma
Gao Xiang, Yijing Ren, Lishan Gao • 2026
-
Immune-inflammation index as prognostic markers in metastatic castration-resistant prostate cancer: a systematic review and meta-analysis
Zitong Qin, Runzhang Liu, Suoshi Jing • 2026
-
Intranodular and perinodular radiomics features based on non-contrast CT to distinguish pulmonary cryptococcosis from lung adenocarcinoma: a two-center study
Yanfang Deng, Lin Lin, Kaiji Deng • 2026
Explore More Journals
Metadata
Last updated: Jul 12, 2026
Updated by: system
Get weekly updates
Free. Monday morning. New citation rates, CFPs, indexing alerts, predatory watch list. One-click unsubscribe.